Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q4 FY2024 Earnings Presentation
39 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, May 23, 2024
Slide 1: Cover letter to stock exchanges
May 23, 2024 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 543950
Slide 2: Q4 & FY24 Earnings Presentation
www.yatharthhospitals.com Q4 & FY24 Earnings Presentation May 23, 2024 1
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t
Slide 4: Q4 & FY24 Performance Highlights
Q4 & FY24 Performance Highlights 3
Slide 5: Key Highlights
Key Highlights Q4 FY24 Rs. 1,778 mn Rs. 6,705 mn +24% YoY +29% YoY +7% QoQ Revenue Margin Rs. 465 mn Margin Rs. 1,799 mn 26.2% +21% YoY +35% YoY 26.8% -58bps YoY +0.2% QoQ EBITDA +113bps YoY Margin Rs. 383 mn Margin Rs. 1,145 mn 21.6% +121% YoY +74% YoY 17.1% +953bps YoY +30% QoQ PAT +443bps YoY Net
Slide 6: Financial Highlights
Financial Highlights Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% +29% +24% 26.8% 27.8% 2,0 1,9 00.00 95.00 28% 1,9 1,9 90.00 85.00 1,9 1,980.00 75.00 1,9 1,9 70.00 65.00 1,9 55.00 1,9 60.00 1,9 45.00 1,9 50.00 1,9 1,9 40.00 35.00 26.8% 1,9 25 1,9 30.00 .0 0 0 27% 1,9 1,920 15 .0 1000 28% 1,9 10 .0 .0 0
Slide 7: Strengthened Balance Sheet
Strengthened Balance Sheet Equity Base Expansion (Rs mn) 40% Debt Repayment – 2,450 mn 8,743 Organic Capex – 1,326 mn 22% Rs 6,100 mn IPO Proceeds 11% Inorganic Expansion – 650 mn 1,830 27% General Corporate & Issue Mar-23 Mar-24 Exps. – 1,674 mn Capex Outlay from IPO proceeds Debt Reduction (Rs mn)
Slide 8: Profit & Loss Summary
Profit & Loss Summary Change Change Change Particulars (Rs Mn) Q4FY24 Q4FY23 Q3FY24 FY24 FY23 YoY QoQ YoY Revenue from Operations 1,778 1,438 24% 1,668 7% 6,705 5203 29% Medical Consumables & 375 257 46% 315 19% 1,333 929 43% Pharmacy items Employee Expenses 319 250 28% 299 7% 1,170 919 27% Other Ex
Slide 9: Balance Sheet
Balance Sheet Particulars (Rs Mn) Mar-24 Mar-23 Particulars (Rs Mn) Mar-24 Mar-23 Shareholders Equity 8,743 1,830 Fixed Assets (incl. Goodwill) 4,405 2,950 Borrowings 831 2,638 Right to Use Assets 14 35 Lease Liabilities 16 36 Financial Assets 243 20 Trade Payables 292 169 Inventories 81 61 Other fi
Slide 10: Operational Highlights
Operational Highlights Total 1,605 Beds 57% Q4FY24 Occupancy Delhi NCR 1,120 Beds Capacity Expansion Occupancy Improvement ✓ Yatharth’s Faridabad hospital (erstwhile Asian ✓ Full year occupancy at 54% in FY24 vs 45% in FY23 Fidelis) in Greater Faridabad was operationalized on May 12, 2024, expanding
Slide 11: Operational KPIs
Operational KPIs IPD & OPD Revenue (Rs mn) IPD & OPD Volumes (in ‘000s) IPD Revenue OPD Revenue IPD Volume OPD Volume 1000 6,705 375 376 93 94 90 1,670 1,778 5,203 819 1,438 216 193 684 171 330 327 81 82 78 5,886 1,477 1,562 4,519 1,267 11 12 12 45 49 Q4FY23 Q3FY24 Q4FY24 FY23 FY24 Q4FY23 Q3FY24 Q4F
Slide 12: Operational KPIs: Revenue, ARPOB, Occupancy
Operational KPIs 6,705 Revenue (Rs mn) 5,203 2,340 1,438 1,670 1,778 1,994 1,721 1,8572,149 1,357 528 442 405 582 435 559 586 469 619 360 64 94 104 131 Q4FY23 Q3FY24 Q4FY24 FY23 FY24 ARPOB (Rs) 35,074 34,287 33,994 32,173 30,475 29,347 29,266 28,571 28,548 27,706 26,554 26,538 26,511 25,184 24,949 2
Slide 13: Our Specialties
Our Specialties Diversified specialty services Noida extension hospital registered 2024 28% 10% 10% 10% 7% 6% 5% 5% 4% 4% highest share of super specialties Nephrology & urology Cardiology 2023 31% 9% 10% 10% 8% 13% 13% Oncology, Internal 10% 2022 50% Medicine 16% Neurosciences FY24 8% 2021 56% Othe
Slide 14: Clinical Achievements during the quarter
Clinical Achievements during the quarter 14
Slide 15: Shareholding Pattern
Shareholding Pattern Key Investors Key Investors 20.13% ICICI Prudential Mutual Fund Canara HSBC Life Insurance Bandhan Mutual Fund Carnelian Capital 3.99% HDFC Mutual Fund Plutus Wealth Management 9.33% Motilal Oswal Funds Grandeur Peak Fund 66.54% Max Life Insurance Think Investments Kotak Mahindr
Slide 16: About The Company
About The Company 16
Slide 17: At a Glance
At a Glance Leading super specialty hospital in North India Among top 10 largest private hospitals One-stop destination for patient needs providing all of Delhi NCR region in terms of number levels of healthcare services from primary to tertiary of beds 5 10 1,605 2019 Noida Extension 2013 Hospitals
Slide 18: Our Journey
Our Journey Growing presence across regions and services 2008 2013 2019 2023 Incorporation of Established our Commencement of Listing on NSE & BSE company and second 250 bedded our third hospital, commencement of hospital, in Noida Noida Extension operations hospital, in May 2019, pursuant to the ac
Slide 19: Greater Noida Hospital Overview
Greater Noida Hospital Overview Revenue from Operations (Rs mn) Provides a wide spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, 2,340 1,994 urology, nephrology, oncology, gastroenterology etc. 1,702 Strategy to develop th
Slide 20: Noida Hospital Overview
Noida Hospital Overview Revenue from Operations (Rs mn) Provides services across 30 specialties, including cardiac sciences, 1,857 orthopedics, nephrology, urology, neurosciences, gastroenterology, etc. 1,721 1,283 681 Strategy to improve ALOS and improve the combination of super specialties, to dri
Slide 21: Noida Extension Hospital Overview
Noida Extension Hospital Overview Super specialties contribute 70% of the overall business at this hospital; Revenue from Operations (Rs mn) continued efforts to develop this hospital as a Centre of Excellence for 2,149 oncology and robotic surgeries 1,357 1,023 In March 2024, a radiation oncology l
Slide 22: Jhansi – Orchha Hospital Overview
Jhansi – Orchha Hospital Overview Revenue from Operations (Rs mn) One of the largest hospital in Jhansi-Orchha-Gwalior region, has 360 infrastructure to operate all the major super specialties Acquired in FY22, aimed at further expanding into new geographies and 131 growing presence in the regional
Slide 23: Faridabad Hospital Overview
Faridabad Hospital Overview On Feb 9, 2024, signed a definitive agreement for 100% acquisition of Asian Fidelis Hospital in Faridabad, Haryana for a purchase consideration of INR 1,160 mn Built 3 years ago with latest facilities on a 1.25-acre land and has an operational bed capacity of 200 beds, wi
Slide 24: Our Specialties: Expanding share of high value specialties
Our Specialties Expanding share of high value specialties Revenue change - FY24 vs FY21 30 Specialties and 3Y CAGR 68% 61% 53% 49% 156% 48% 72% 114% 54% Super specialties including 10 Centers of FY2021 FY2024 Revenue (Rs. mn) Excellence (COE) Our COEs ➢ Centre of Internal Medicine 71 488 348 666 288
Slide 25: Our Strengths
\¢ 25 OUR STRENGTHS
Slide 26: Strengths
Strengths Among the leading super-specialty hospital Regional advantage in Delhi NCR Advanced and high-end medical Experienced and professional equipment and technology management team Track record of stable Team of highly qualified operating & financial medical professionals performance 26
Slide 27: Leading hospital in Delhi NCR, attracts patients from adjoining states
Leading hospital in Delhi NCR, attracts patients from adjoining states with inadequate healthcare facilities 2 of Yatharth’s hospitals are amongst top 10 largest private Delhi NCR region, Faridabad - Haryana hospitals in Delhi NCR* Jhansi-Orchha- ➢ Noida, Greater Noida and Noida extension attract pa
Slide 28: Regional Advantage
Regional Advantage Integrating talent from First mover advantage in well-established allied building out network workforce across Tier II/III cities Promoters being Stronger local connect doctors, have better with people 28 connect with doctors
Slide 29: Advanced and high-end medical equipment and technology
Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce cutting-edge medical technology and state-of-the-art equipment • Catheterization Laboratory Diagnostic Certifications • Computerized Tomograph
Slide 30: Experienced and professional management team
Experienced and professional management team Leadership Promoted by experienced medical professionals, Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Chairman & Whole-time Director Managing Director Management Led by experienced and qualified professional management te
Slide 31: Track record of stable operating and financial performance
Track record of stable operating and financial performance Growth led by strong operational Optimizing Capex Allocation 1. Stable operating & efficiency: 1. Reinvesting in increasing bed financial performance 1. Streamlining clinical and capacity and opening new hospitals 2. Continued growth over th
Slide 32: Growth Strategy
Growth Strategy Continue to Introduce new Grow medical Augment scale Further leverage improve our specialties at tourism segment through organic technology to quality of care existing hospitals to attract and inorganic grow operations and operational international manner in current efficiencies pati
Slide 33: Key Growth Drivers (1/2)
Key Growth Drivers (1/2) Improving specialty mix Introduce new specialties at Grow medical tourism segment towards high value specialties existing hospitals to attract international patients ➢ Increase in share of higher value ➢ Unveiled state of the art Cancer ➢ Close proximity to the upcoming spec
Slide 34: Key Growth Drivers (2/2)
Key Growth Drivers (2/2) Leverage technology to grow Improving utilization & Jhansi Targeting Balanced Growth operations hospital stabilization ➢ Augment scale through organic ➢ Adopt the latest medical ➢ Focus towards increasing ARPOB and inorganic manner in current technologies and equipment to an
Slide 35: Appendix
Appendix 35
Slide 36: Board of Directors (1/2)
Board of Directors (1/2) Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Yatharth Tyagi Chairman & Whole-time Director Managing Director Whole-time Director ➢ Over 17 years of experience in medical ➢ Over 17 years of experience in medicine ➢ Associated with the company since 2019 care and hospital management a
Slide 37: Board of Directors (2/2)
Board of Directors (2/2) Promila Bhardwaj Mukesh Sharma Sanjeev Upadhyaya Independent Director Independent Director Independent Director ➢ Over 35 years of experience in public ➢ Over 35 years of experience in banking ➢ Over 20 years of experience in administration ➢ Previously associated with Bank
Slide 38: Management Team
Management Team Amit Kumar Singh Pankaj Prabhakar Deepak Kumar Tyagi Chief Executive Officer Chief Financial Officer President, Strategy and Finance ➢ Over 17 years of experience in hospital ➢ Over 16 years of experience incorporate ➢ Approximately 14 years of experience management finance of severa
Slide 39: Thank You
Thank You www.yatharthhospitals.com Yatharth Hospital & Trauma Care Services Ltd CIN: L85110DL2008PLC174706 www.yatharthhospitals.com Investor Relations investor.relations@yatharthhospitals.com 39
Yatharth Hospital & Trauma Care Services — Q4 FY2024 Earnings Presentation on 6ix